Jinhai Medical Technology Limited (HKG: 2225)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.05
+0.02 (0.33%)
Sep 27, 2024, 4:08 PM HKT

Jinhai Medical Technology Statistics

Total Valuation

Jinhai Medical Technology has a market cap or net worth of HKD 7.54 billion. The enterprise value is 7.50 billion.

Market Cap 7.54B
Enterprise Value 7.50B

Important Dates

The next estimated earnings date is Friday, November 29, 2024.

Earnings Date Nov 29, 2024
Ex-Dividend Date n/a

Share Statistics

Jinhai Medical Technology has 1.29 billion shares outstanding. The number of shares has increased by 3.58% in one year.

Shares Outstanding 1.29B
Shares Change (YoY) +3.58%
Shares Change (QoQ) +2.93%
Owned by Insiders (%) 48.94%
Owned by Institutions (%) n/a
Float 660.00M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 21.64
PB Ratio 34.80
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -128.60
EV / Sales 21.85
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -832.98

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.30.

Current Ratio 1.54
Quick Ratio 1.43
Debt / Equity 0.30
Debt / EBITDA n/a
Debt / FCF -7.23
Interest Coverage -21.73

Financial Efficiency

Return on equity (ROE) is -33.74% and return on invested capital (ROIC) is -17.71%.

Return on Equity (ROE) -33.74%
Return on Assets (ROA) -12.63%
Return on Capital (ROIC) -17.71%
Revenue Per Employee 675,752
Profits Per Employee -114,791
Employee Count 694
Asset Turnover 1.07
Inventory Turnover 17.24

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +189.47% in the last 52 weeks. The beta is 0.04, so Jinhai Medical Technology's price volatility has been lower than the market average.

Beta (5Y) 0.04
52-Week Price Change +189.47%
50-Day Moving Average 5.11
200-Day Moving Average 4.15
Relative Strength Index (RSI) 58.26
Average Volume (20 Days) 1,124,150

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Jinhai Medical Technology had revenue of HKD 343.28 million and -58.31 million in losses. Loss per share was -0.05.

Revenue 343.28M
Gross Profit 82.95M
Operating Income -65.10M
Pretax Income -56.16M
Net Income -58.31M
EBITDA -49.38M
EBIT -65.10M
Loss Per Share -0.05
Full Income Statement

Balance Sheet

The company has 101.82 million in cash and 65.10 million in debt, giving a net cash position of 36.72 million or 0.03 per share.

Cash & Cash Equivalents 101.82M
Total Debt 65.10M
Net Cash 36.72M
Net Cash Per Share 0.03
Equity (Book Value) 217.13M
Book Value Per Share 0.17
Working Capital 75.16M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.27 million and capital expenditures -7.74 million, giving a free cash flow of -9.00 million.

Operating Cash Flow -1.27M
Capital Expenditures -7.74M
Free Cash Flow -9.00M
FCF Per Share -0.01
Full Cash Flow Statement

Margins

Gross margin is 24.17%, with operating and profit margins of -18.96% and -16.99%.

Gross Margin 24.17%
Operating Margin -18.96%
Pretax Margin -16.36%
Profit Margin -16.99%
EBITDA Margin -14.38%
EBIT Margin -18.96%
FCF Margin -2.62%

Dividends & Yields

Jinhai Medical Technology does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.58%
Shareholder Yield -3.58%
Earnings Yield n/a
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Jinhai Medical Technology has an Altman Z-Score of 14.76.

Altman Z-Score 14.76
Piotroski F-Score n/a